Axsome Posts Mixed Phase III Data in Alzheimer’s A...
Category : Approval/Launch 3 January 2025With two earlier trials meeting their primary endpoints, Axsome claimed it has the data to support a...
With two earlier trials meeting their primary endpoints, Axsome claimed it has the data to support a...
SciSparc Ltd. a specialty clinical-stage pharmaceutical company focusing on the development of thera...
Argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the live...
MedMira Inc. (MedMira), a leading developer and manufacturer of Rapid Vertical Flow diagnostics, ann...
AVITA Medical, Inc., a commercial-stage regenerative medicine company focused on first-in-class devi...